Please try another search
Medesis Pharma SA is a France-based clinical development stage biopharmaceutical Company. The Company is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.
Name | Age | Since | Title |
---|---|---|---|
Cedric Navas | - | 2021 | Member of the Supervisory Board |
Sylvie Mader | - | - | Member of International Scientific Advisory Board - Oncology |
Olivier Connes | - | 2021 | Chairman of the Supervisory Board |
Jean-Marie Cazaledes | - | 2021 | Member of the Supervisory Board |
Serge Gauthier | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Gerald Batist | - | - | Member of International Scientific Advisory Board - Oncology |
Jacques Touchon | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Jean-Philippe Causse | - | 2021 | Member of the Supervisory Board |
Claudio Cuello | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Paul Loubet | - | - | Member of International Scientific Advisory Board - Infectious diseases |
Guy A. Rouleau | - | - | Member of International Scientific Advisory Board - Neuro-Psychiatry |
Bernard Connes | - | 2021 | Vice-Chairman of the Supervisory Board |
George Lyketsos | - | 2023 | Member of Scientific Advisory Board |
Cecilia Marelli | - | 2023 | Member of Scientific Advisory board |
Edward N. Wilson | - | 2023 | Member of Scientific Advisory Board |
Maria Soto Martin | - | 2023 | Member of Scientific Advisory board |
Zahinoor Ismail | - | 2023 | Member of Scientific Advisory Board |
Mahmoud Pouladi | - | 2023 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review